Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The possibility that hypersecretion of corticotropin-releasing factor (CRF) contributes to the hyperactivity of the hypothalamo-pituitary-adrenal axis observed in patients with major depression was investigated by measuring the concentration of this peptide in cerebrospinal fluid of normal healthy volunteers and in drug-free patients with DSM-III diagnoses of major depression, schizophrenia, or dementia. When compared to the controls and the other diagnostic groups, the patients with major depression showed significantly increased cerebrospinal fluid concentrations of CRF-like immunoreactivity; in 11 of the 23 depressed patients this immunoreactivity was greater than the highest value in the normal controls. These findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA alterations correlate with impaired cognitive function 66,67 in depressed patients”
From Major depressive disorder (2016) · cites this paper as [67]
In the citing paper
“elevated basal cerebrospinal fluid CRH levels”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Nemeroff et al., 1984
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citationCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Corticotropin-Releasing Factor: Actions on the Sympathetic Nervous System and Metabolism*
BROWN, M. R., FISHER, L. A., SPIESS, J., RIVIER, C., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-111-3-928 · Cited by 651
Self-citationNeuroendocrine Regulation in Depression: II. Discrimination of Depressed From Nondepressed Patients
Carroll, B. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090041003 · Cited by 627
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 481
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus
Bloom, F. E., Battenberg, E. L. F., Rivier, J., & Vale, W. (1982) · Regulatory Peptides · doi:10.1016/0167-0115(82)90107-0 · Cited by 364
Self-citationGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Research works printed but not linked: 6
- Carroll, B. J., Handbook on Depression: 325 (1977).
- FISHMAN, A.J., PEPTIDES 1: 149 (1982).
- Rivier, J., Proceedings of the National Academy of Sciences of the United States of America 80: 4851 (1983).
- SNEDECOR, G.W., STAT METHODS: 271 (1967).
- SOKAL, R.R., BIOMETRY: 391 (1969).
- WHYBROW, P.C., MOOD DISORDERS NEW P: 1 (1984).
Cited by
Items 501–600 of 1,001
SIRINATHSINGHJI, D. J. S. (1987) · Brain Research · doi:10.1016/0006-8993(87)91236-4 · Cited by 80
Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline
Scalco, A. Z., Rondon, M. U., Trombetta, I. C., Laterza, M. C., Azul, J. B., Pullenayegum, E. M., Scalco, M. Z., Kuniyoshi, F. H., Wajngarten, M., Negrão, C. E., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283310ece · Cited by 75
Samuelsson, A., Öhrn, I., Dahlgren, J., Eriksson, E., Angelin, B., Folkow, B., & Holmäng, A. B. (2004) · Endocrinology · doi:10.1210/en.2004-0742 · Cited by 82
“Consistent with our findings in IL-6-exposed rats, depressed patients have elevations of CRF mRNA levels in the hypothalamus (69) and CRF protein in cerebrospinal fluid (70).”
BackgroundStrome, E. M., Wheler, G. H. T., Higley, J. D., Loriaux, D. L., Suomi, S. J., & Doudet, D. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232480899 · Cited by 75
Phillips, C. (2017) · Neural Plasticity · doi:10.1155/2017/7014146 · Cited by 65
Wang, S.-S., Xue-bo, Y., Hofman, M. A., Swaab, D. F., & Zhou, J. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-0329-1 · Cited by 82
Perinatal circumstances and risk of offspring suicide: Birth cohort study
Riordan, D. V., Selvaraj, S., Stark, C. R., & Gilbert, J. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.105.015974 · Cited by 79
Jehn, C. F., Kühnhardt, D., Bartholomae, A., Pfeiffer, S., Schmid, P., Possinger, K., Flath, B. C., & Lüftner, D. (2010) · Integrative Cancer Therapies · doi:10.1177/1534735410370036 · Cited by 70
Schüle, C., Baghai, T. C., Eser, D., & Rupprecht, R. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.52 · Cited by 73
Cross-Sensitization Between Immune And Non-Immune Stressors: A Role in the Etiology of Depression?
Tilders, J. H., & Schmidt, E. D. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_11 · Cited by 75
Bangasser, D. A., Dong, H., Carroll, J., Plona, Z., Ding, H., Rodriguez, L., McKennan, C., Csernansky, J. G., Seeholzer, S. H., & Valentino, R. J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.185 · Cited by 69
Corticotropin-Releasing Hormone, Glutamate, and γ-Aminobutyric Acid in Depression
Gao, S.-F., & Bao, A.-M. (2011) · The Neuroscientist · doi:10.1177/1073858410361780 · Cited by 72
Adult hippocampal neurogenesis: Is it the alpha and omega of antidepressant action?
Eliwa, H., Belzung, C., & Surget, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.08.005 · Cited by 78
Holsboer, F. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb08556.x · Cited by 73
Delbende, C., Contesse, V., Mocaër, E., Kamoun, A., & Vaudry, H. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90284-w · Cited by 73
The CRF system as a therapeutic target for neuropsychiatric disorders
Sanders, J., & Nemeroff, C. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.09.004 · Cited by 72
“More than three decades of research implicate CRF in the MDD pathogenesis [5, 34, 35].”
BackgroundResultInfluentialSelf-citationAlcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF
Hauser, S. R., Getachew, B., Taylor, R. E., & Tizabi, Y. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.08.014 · Cited by 71
“Disruptions in the hypothalamic-pituitary-adrenal (HPA) axis have also been implicated in both depression and alcoholism, dampening the ability to cope with stress in both populations (Nemeroff et al., 1984; Lovallo et al. 2000; O'Malley et al. 2002; Kiefer and Wiedemann, 2004; Adinoff et al. 2005; Nemeroff and Vale,…”
BackgroundGray, J. M., Wilson, C. D., Lee, T. T. Y., Pittman, Q. J., Deussing, J. M., Hillard, C. J., McEwen, B. S., Schulkin, J., Karatsoreos, I. N., Patel, S., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.01.004 · Cited by 67
“In this regard, a hallmark feature of clinical studies examining stress-related disorders, such as major depression, is a significant increase in central CRH levels (Nemeroff et al., 1984).”
BackgroundGoldstein, J. M., Holsen, L., Huang, G., Hammond, B. D., James-Todd, T., Cherkerzian, S., Hale, T. M., & Handa, R. J. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/jgoldstein · Cited by 72
Arya, S., Lee, S., Zahner, G. J., Cohen, B. E., Hiramoto, J. S., Wolkowitz, O. M., Khakharia, A., Binney, Z. O., & Grenon, S. M. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.10.092 · Cited by 77
Lahmame, A., Grigoriadis, D. E., Souza, E. B. D., & Armario, A. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01368-6 · Cited by 73
Personality, Stress, and Disease: An Interactionist Perspective
Eysenck, H. J. (1991) · Psychological Inquiry · doi:10.1207/s15327965pli0203_1 · Cited by 88
Neurological and Psychiatric Adverse Effects of Immunological Therapy
Meyers, C. A., & Valentine, A. D. (1995) · CNS Drugs · doi:10.2165/00023210-199503010-00006 · Cited by 75
Animal inflammation-based models of depression and their application to drug discovery
Ma, L., Demin, K. A., Kolesnikova, T. O., Kharsko, S. L., Zhu, X., Yuan, X., Song, C., Meshalkina, D. A., Leonard, B. E., Tian, L., et al. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1362385 · Cited by 68
Neurochemical Correlates of Sympathetic Activation during Severe Alcohol Withdrawal
Hawley, R. J., Nemeroff, C. B., Bissette, G., Guidotti, A., Rawlings, R., & Linnoila, M. (1994) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb01429.x · Cited by 73
Self-citationVeith, R. C., Lewis, N., Langohr, J. I., Murburg, M. M., Ashleigh, E. A., Castillo, S., Peskind, E. R., Pascualy, M., Bissette, G., Nemeroff, C. B., et al. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90002-x · Cited by 74
“CRF measurements were performed by radioimmunoassay (RIA) as previously described (Nemeroff et al., 1984) with a C-terminally directed antiserum.”
MethodSelf-citationThe oCRH stimulation test before and after clinical recovery from depression
Amsterdam, J. D., Maislin, G., Winokur, A., Berwish, N. J., Kling, M. A., & Gold, P. W. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90037-7 · Cited by 76
Are there meaningful biomarkers of treatment response for depression?
Breitenstein, B., Scheuer, S., & Holsboer, F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.002 · Cited by 74
Cerebrospinal fluid-contacting neurons: multimodal cells with diverse roles in the CNS
Wyart, C., Tano, M. C., Cantaut-Belarif, Y., Orts-Del’Immagine, A., & Böhm, U. L. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00723-8 · Cited by 75
Tresadern, G., Bemporad, D., & Howe, T. J. (2009) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2009.01.003 · Cited by 76
Poole, L., & Steptoe, A. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.07.009 · Cited by 73
Hypothalamic‐Pituitary‐Adrenal Axis and Suicide
Arató, M., Bánki, C. M., Nemeroff, C. B., & Bissette, G. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb27905.x · Cited by 69
Self-citationDinan, T. G. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.2238 · Cited by 70
“Elevated CSF levels of CRH- immunoreactivity (4), together with blunted CRH-stimulated ACTH release, have also been reported (5, 6).”
BackgroundSymposium on ‘Nutrition and the elderly’ Protein-energy malnutrition in older subjects
Morley, J. E. (1998) · Proceedings of The Nutrition Society · doi:10.1079/pns19980085 · Cited by 79
Dijkstra, I., Tilders, F. J. H., Aguilera, G., Kiss, A., Rabadan-Diehl, C., Barden, N., Karanth, S., Holsboer, F., & Reul, J. M. H. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03909.1998 · Cited by 70
“In line with this notion is the observation that patients with major depression show increased CRH levels in the cerebrospinal fluid (Nemeroff et al., 1984; Banki et al., 1992), increased numbers of CRH and CRH/vasopressin (AVP)expressing neurons in the PVN, (Raadsheer et al., 1994), and increased…”
CRH Overproduction in Transgenic Mice: Behavioral and Immune System Modulationa
Stenzel‐Poore, M. P., Duncan, J. E., Rittenberg, M. B., Bakke, A. C., & Heinrichs, S. C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb15110.x · Cited by 77
Hypothesis: Cytokines may be activated to cause depressive illness and chronic fatigue syndrome
Ur, E., White, P. D., & Grossman, A. B. (1992) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02195983 · Cited by 70
“Indeed, Nemeroff et al. (1984) and Banki et al. (1987) have shown raised levels of immunoreactive CRH-41 in the cerebrospinal fluid of depressed subjects, with evidence that this is a state dependent finding (Nemeroff et al. 1991), although not all studies have been equally conclusive.”
ResultCaberlotto, L., & Hurd, Y. L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00231-1 · Cited by 68
“…have received the main focus in this line of research, but neuropeptides such as somatostatin (Rubinow 1986), corticotrophin-releasing factor (Nemeroff et al. 1984), and endogenous opioids (Gross-Isseroff et al. 1990; Scarone et al. 1990) have also been studied in relation to depressive…”
BackgroundPomara, N., Singh, R., Deptula, D., LeWitt, P. A., Bissette, G., Stanley, M., & Nemeroff, C. B. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90071-1 · Cited by 68
“This finding is consistent with our previous report (Nemeroff et al. 1984) in which there was no difference in CSF CRF-LI concentrations in a mixed group of demented patients, including patients with a clinical diagnosis of AD.”
BackgroundMethodResultSelf-citationHatzinger, M. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150573 · Cited by 52
Wieczorek, L., Fish, E. W., O’Leary‐Moore, S. K., Parnell, S. E., & Sulik, K. K. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.01.005 · Cited by 67
“Of particular interest for the current study is the association of anxiety and depression with altered hypothalamic-pituitary-adrenal (HPA) axis activity (Burke, Davis, Otte, & Mohr, 2005; Nemeroff et al., 1984; Vreeburg et al., 2009; Wingenfeld & Wolf, 2011; Young, Abelson, & Cameron, 2004).”
BackgroundCRH Signaling: Molecular Specificity for Drug Targeting in the CNS
Refojo, D., & Holsboer, F. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04983.x · Cited by 65
Oshima, A., Flachskamm, C., Reul, J. M. H. M., Holsboer, F., & Linthorst, A. C. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300267 · Cited by 70
“Enhanced levels of CRH in the cerebrospinal fluid (Nemeroff et al, 1984), decreased numbers of CRH-binding sites in the frontal cortex (Nemeroff et al, 1988), an increased number of CRH-expressing neurons in the hypothalamic paraventricular nucleus (Raadsheer et al, 1994), and an elevated level of…”
BackgroundPotential mechanisms linking psychological stress to bone health
Ng, J.-S., & Chin, K.-Y. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.50680 · Cited by 66
“Hypersecretion of cortisol, a key feature in chronic psychological stress, occurs due to dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis [20-22].”
Janssen, D., & Kozicz, T. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00028 · Cited by 74
Maes, M. H. J., Meltzer, H. Y., Stevens, W. J., Calabrese, J. R., & Cosyns, P. R. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90079-5 · Cited by 69
Regulation of corticosteroid receptor gene expression in depression and antidepressant action.
Barden, N. (1999) · PubMed Central · Cited by 79
Lesch, K., Laux, G., Schulte, H. M., Pfüller, H., & Beckmann, H. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90136-9 · Cited by 70
Elevated CSF dynorphin A [1–8] in Tourette's syndrome
Leckman, J. F., Riddle, M. A., Berrettini, W. H., Anderson, G. M., Hardin, M., Chappell, P., Bissette, G., Nemeroff, C. B., Goodman, W. K., & Cohen, D. J. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90575-9 · Cited by 66
Self-citationKathol, R. G., Jaeckle, R. S., Lopez, J. F., & Meller, W. H. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.155.4.468 · Cited by 66
Goldstein, J. M., Holsen, L., Handa, R., & Tobet, S. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00247 · Cited by 63
“…and non-suppression of cortisol secretion on the dexamethasone suppression test in MDD (Carroll et al., 1976, 1981; Jarrett et al., 1983; Nemeroff et al., 1984; Halbreich et al., 1985; Holsboer et al., 1985; Banki et al., 1987; Evans and Nemeroff, 1987; Rubin et al., 1987; Heim et al.,…”
BackgroundRoss, J. A., Gliebus, G., & Van Bockstaele, E. J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.004 · Cited by 61
Pavcovich, L. A., & Valentino, R. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00401.1997 · Cited by 65
“Consistentwiththis,evidenceexistsforhypersecretionofneurohormone CRF in depressed subjects ( Nemeroff et al., 1984 ).”
Endogenous biochemical abnormalities in affective illness: Therapeutic versus pathogenic
Post, R. M., & Weiss, S. R. B. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90216-m · Cited by 73
Interaction of Stress, Corticotropin-Releasing Factor, Arginine Vasopressin and Behaviour
Beurel, E., & Nemeroff, C. B. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_306 · Cited by 64
“The role of the CRF system in depression has been supported by clinical studies showing that depressed patients have higher CSF concentrations of CRF (Nemeroff et al., 1984), and depressed patients who died by suicide exhibit increased expression of CRF mRNA in the hypothalamus and PFC (Austin et al.”
ResultSelf-citationDepression and its association with diabetes, cardiovascular disease, and birth weight
Paile‐Hyvärinen, M., Räikkönen, K., Forsén, T., Kajantie, E., Ylihärsilä, H., Salonen, M. K., Osmond, C., & Eriksson, J. G. (2007) · Annals of Medicine · doi:10.1080/07853890701545722 · Cited by 87
“However, one often-suggested mechanism is altered function of the hypothalamic-pituitaryadrenal (HPA) axis, which is reflected by the elevated cortisol levels seen in all three disorders (21,22,28).”
BackgroundWebb, M. A., Davies, M. J., Ashra, N., Bodicoat, D. H., Brady, E. M., Webb, D. R., Moulton, C. D., Ismail, K., & Khunti, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187448 · Cited by 69
Kornfield, S. L., Hantsoo, L., & Epperson, C. N. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0907-x · Cited by 57
Hartz, R. A., Arvanitis, A. G., Arnold, C. R., Rescinito, J. P., Hung, K. L., Zhang, G., Wong, H. H., Langley, D. R., Gilligan, P. J., & Trainor, G. L. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.097 · Cited by 65
Garza, R. D. L., & Asnis, G. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02757-4 · Cited by 67
Curtis, A. L., & Valentino, R. J. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90172-4 · Cited by 63
The Role of the Glucocorticoids in Developing Resilience to Stress and Addiction
Srinivasan, S., Shariff, M. R., & Bartlett, S. E. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00068 · Cited by 69
“of the HPA axis by chronic and uncontrollable stress leads to abnormal GC secretion (35, 36).”
BackgroundSalaria, S., Chana, G., Caldara, F., Feltrin, E., Altieri, M., Faggioni, F., Domenici, E., Merlo-Pich, E., & Everall, I. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.05.003 · Cited by 58
Rasmusson, A. M., & Pineles, S. L. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0908-9 · Cited by 66
The neurobiology of aging: Does it predispose to depression?
Veith, R. C., & Raskind, M. A. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80034-4 · Cited by 68
Corticotropin-releasing hormone challenge in prepubertal major depression
Birmaher, B. B., Dahl, R. E., Perel, J. M., Williamson, D. E., Nelson, B., Stull, S. D., Kaufman, J., Waterman, G. S., Rao, U., Nguyen, N., et al. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00177-8 · Cited by 68
Post, R. M., Weiss, S. R. B., & Leverich, G. S. (1994) · Development and Psychopathology · doi:10.1017/s0954579400004788 · Cited by 64
Kalin, N. H., Shelton, S. E., Barksdale, C. M., & Brownfield, M. S. (1987) · Brain Research · doi:10.1016/0006-8993(87)90894-8 · Cited by 62
Carroll, B. J., Iranmanesh, A., Keenan, D. M., Cassidy, F., Wilson, W. H., & Veldhuis, J. D. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01821.x · Cited by 54
Moreno, F. A., Parkinson, D., Palmer, C., Castro, W. L., Misiaszek, J., El Khoury, A., Mathé, A. A., Wright, R., & Delgado, P. L. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.10.003 · Cited by 61
Hsu, D. T., Mickey, B. J., Langenecker, S. A., Heitzeg, M. M., Love, T., Wang, H., Kennedy, S. E., Peciña, M., Shafir, T., Hodgkinson, C. A., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5533-11.2012 · Cited by 70
“…dysregulation in MDD (Holsboer and Barden, 1996), and central CRH hypersecretion has been demonstrated by elevated basal levels of CRH-like immunoreactivity in the CSF of MDD patients and suicide victims (Nemeroff et al., 1984; Bánki et al., 1987; Widerlöv et al., 1988; Arató et al., 1989).”
BackgroundBruijnzeel, A. W., Ford, J., Rogers, J. A., Scheick, S., Ji, Y., Bishnoi, M., & Alexander, J. C. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.12.001 · Cited by 59
“CRF levels are elevated in depressed patients and treatment with antidepressant drugs improves mood states and decreases brain CRF levels (De Bellis et al., 1993; Nemeroff et al., 1984).”
BackgroundAtkinson, H. C., Leggett, J. D., Wood, S. A., Castrique, E. S., Kershaw, Y. M., & Lightman, S. L. (2010) · Endocrinology · doi:10.1210/en.2010-0101 · Cited by 68
“Depression is frequently characterized by increased basal HPA activity (34).”
BackgroundAdinoff, B. H., Anton, R., Linnoila, M., Guidotti, A., Nemeroff, C. B., & Bissette, G. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00212-v · Cited by 61
Self-citationGold, P. W., & Chrousos, G. P. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.5 · Cited by 68
Corticotropin releasing factor receptor antagonists for major depressive disorder
Paez-Pereda, M., Hausch, F., & Holsboer, F. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.565330 · Cited by 58
“4 The need for patient stratification for CRF1 receptor antagonist treatment A careful analysis of the data on CRF levels in the cerebrospinal fluid of depressive patients in comparison to normal subjects shows that among the depressive population some individuals have increased amounts while some others are within th…”
BackgroundInfluentialLaryea, G., Arnett, M. G., & Muglia, L. J. (2012) · Behavioral Sciences · doi:10.3390/bs2020135 · Cited by 57
“A subpopulation of patients with major depression and post-traumatic stress disorder (PTSD) have elevated levels of CRH in their cerebrospinal fluid [33,34] Moreover, HPA axis hyperactivity is the most commonly observed neuroendocrine change in major depressive disorder (MDD).”
BackgroundCellular and molecular mechanisms of sexual differentiation in the mammalian nervous system
Forger, N. G., Strahan, J. A., & Castillo-Ruiz, A. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.01.001 · Cited by 57
“CRF and its receptor 1 (CRF1) are considered paramount mediators of stress-related psychopathology because altered expression of both have been linked to the development of conditions such as post-traumatic stress disorder and major depression (Banki et al., 1987; Bremner et al., 1997; Merali et al., 2004; Nemeroff et…”
BackgroundMolecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders
Juruena, M. F., Cleare, A. J., Bauer, M. E., & Pariante, C. M. (2003) · Acta Neuropsychiatrica · doi:10.1046/j.1601-5215.2003.00051.x · Cited by 59
“Moreover, depressed patients exhibit increased concentrations of CRH in the CSF, increased CRH mRNA and protein in the paraventricular nucleus (PVN) of the hypothalamus (postmortem samples), and a blunted ACTH response to a CRH challenge (3,4).”
BackgroundInfluentialStress, Depression, and The Role of Cytokines
Leonard, B. E., & Song, C. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_14 · Cited by 66
France, R. D., Urban, B. J., Krishnan, K. R. R., Bissett, G., Bánki, C. M., Nemeroff, C. B., & Speilman, F. J. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90108-4 · Cited by 69
Self-citationLicinio, J., & Frost, P. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000001000003 · Cited by 58
Maes, M. H. J., Meltzer, H. Y., D'Hondt, P., Cosyns, P. R., & Blockx, P. P. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00049-g · Cited by 59
Molchan, S. E., Hill, J. L., Martinez, R. A., LAWLOR, B. A., Mellow, A. M., Rubinow, D. R., Bissette, G., Nemeroff, C. B., & Sunderland, T. (1993) · Psychoneuroendocrinology · doi:10.1016/0306-4530(93)90044-l · Cited by 64
Self-citationRUPPRECHT, R., LESCH, K.-P., MULLER, U., BECK, G., BECKMANN, H., & SCHULTE, H. M. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-600 · Cited by 58
Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients
Spiliotaki, M., Salpeas, V., Malitas, P., Alevizos, V., & Moutsatsou, P. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.02.006 · Cited by 58
“BD patients exhibit elevated basal cortisol levels in plasma and urine, increased release of CRH (corticotrophin releasing hormone) in the hypothalamus and hypertrophy of the pituitary and adrenal glands (Nemeroff et al., 1984; Raadsheer et al., 1994; Rubin et al., 1995; Manji et al., 2001a).”
BackgroundSuarez, E. C., Sundy, J. S., & Erkanli, A. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.09.008 · Cited by 62
Perinatal exposure to bisphenol A at the intersection of stress, anxiety, and depression
Wiersielis, K., Samuels, B. A., & Roepke, T. A. (2020) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2020.106884 · Cited by 64
“Indeed, the development of stress-related psychiatric disorders is associated with this dysregulation, as increased CRF concentrations are found in individuals with these disorders (Bremner et al., 1997; Gold et al., 1996; Gold and Chrousos, 1985; Nemeroff et al., 1991; Nemeroff et al., 1984).”
BackgroundZhang, W., & Rosenkranz, J. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.03.028 · Cited by 55
CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture
Nishino, S., Ripley, B. A., Mignot, E. J.-M., Benson, K. L., & Zarcone, V. P. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00032-x · Cited by 65
“, 1987), a finding akin to those reported in major depression (Nemeroff et al., 1984; Roy et al., 1987).”
ResultPSYCHONEUROENDOCRINOLOGY OF DEPRESSION
Young, E. A., & Korszun, A. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70007-1 · Cited by 65
PLASMA CORTICOTROPHIN‐RELEASING FACTOR AND VASOPRESSIN RESPONSES TO HYPOGLYCAEMIA IN NORMAL MAN
Ellis, M. J., Schmidli, R. S., Donald, R. A., Livesey, J., & Espiner, E. A. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03754.x · Cited by 62
Maciag, C. M., Dent, G., Gilligan, P., He, L., Dowling, K., Ko, T., Levine, S., & Smith, M. A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00398-0 · Cited by 62
“The consistent preclinical results as well as clinical data indicating that CSF CRF levels are elevated in melancholic depression (Nemeroff et al. 1984) have led to speculation that a non-peptide CRF antagonist might prove to have antidepressant and anxiolytic properties (Holsboer 1999; Gilligan et…”
ResultEthyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression
Murck, H., Song, C., Horrobin, D. F., & Uhr, M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004249 · Cited by 57
Early-life stress, corticotropin-releasing factor, and serotonin transporter gene: A pilot study
Coplan, J. D., Abdallah, C. G., Kaufman, J., Gelernter, J., Smith, E. L. P., Perera, T. D., Dwork, A. J., Kaffman, A., Gorman, J. M., Rosenblum, L. A., et al. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.011 · Cited by 55
“Assays for CRF were performed according to the methods described in Nemeroff et al. (1984).”
BackgroundMethodSelf-citationBranchi, I., Santarelli, S., D’Andrea, I., & Alleva, E. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.01.003 · Cited by 60
Hartz, R. A., Ahuja, V. T., Zhuo, X., Mattson, R. J., Denhart, D. J., Deskus, J. A., Vrudhula, V. M., Pan, S., Ditta, J. L., Shu, Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900716v · Cited by 61
Pathogenic involvement of neuropeptides in anxiety and depression
Alldredge, B. (2010) · Neuropeptides · doi:10.1016/j.npep.2009.12.014 · Cited by 63
Corticotropin-releasing factor (CRF) — a review
Emeric-Sauval, E. (1986) · Psychoneuroendocrinology · doi:10.1016/0306-4530(86)90014-4 · Cited by 57
Landmann, R., Schaub, B., Link, S., & Wacker, H. R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00176-x · Cited by 45
Metadata
- Authors
- Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W.
- Affiliations
- Duke University (US)
- Uppsala University (SE)
- Duke Medical Center (US)
- University of Gothenburg (SE)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1984-12-14
- Volume
- 226
- Issue
- 4680
- Pages
- 1342-1344
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1974253960
- Semantic Scholar
- 1a0f9dda77d66396db9247777d53158b0628b325
- Cited by
- 1,485
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 34 · 2016: 36 · 2015: 34 · 2014: 46 · 2013: 39 · 2012: 37
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, cerebrospinal fluid, major depressive disorder, hypothalamic-pituitary-adrenal axis, hypersecretion, schizophrenia, dementia
- MeSH terms
- Adult, Aged, Corticotropin-Releasing Hormone, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Radioimmunoassay, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.